Bridget Cole
About Bridget Cole
Bridget Cole is the Chief Scientific Officer with over 25 years of experience in drug discovery and clinical development, specializing in advancing compounds across various therapeutic areas.
Bridget Cole as Chief Scientific Officer
Bridget Cole was appointed as Chief Scientific Officer in November 2023. She brings over 25 years of experience in drug discovery and clinical development. In her current role, she leverages her extensive background to oversee scientific strategies and propel innovations forward. Her appointment signifies a strategic move to enhance the company's scientific capabilities.
Bridget Cole's Experience in Drug Discovery and Clinical Development
Bridget Cole has over 25 years of experience in drug discovery and clinical development. She has played pivotal roles in advancing compounds from lead identification through late-stage clinical trials across various therapeutic areas. Her work at different biopharmaceutical companies showcases her expertise in taking therapeutic compounds through various stages of development to address unmet medical needs.
Bridget Cole's Previous Roles at 1910 Genetics and Nocion Therapeutics
Before her current role, Bridget Cole served as the Senior Vice President and Head of Chemistry at 1910 Genetics. Prior to that, she worked at Nocion Therapeutics as the SVP of Drug Discovery, where she led lead optimization programs and developed a phase 2 drug candidate for chronic cough. Her leadership in medicinal chemistry and drug discovery has been instrumental in progressing new therapeutic candidates.
Educational Background of Bridget Cole
Bridget Cole received her bachelor's degree in chemistry from Boston University and went on to earn her Ph.D. in organic chemistry from Brandeis University. She also completed her postdoctoral training at Boston College. Her solid academic foundation in chemistry underpins her extensive career in biopharmaceutical research and development.
Bridget Cole's Contributions to Intellectual Property
Throughout her career, Bridget Cole has been a co-inventor on 30 issued U.S. patents. These patents reflect her contributions to the field of medicinal chemistry and drug discovery. Her ability to innovate and protect intellectual property has been a crucial aspect of her career, aiding in the advancement of therapeutic candidates.